Biofil Chemicals and Pharmaceuticals Limited

BSE:524396 Stock Report

Market Cap: ₹1.3b

Biofil Chemicals and Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

Biofil Chemicals and Pharmaceuticals has a total shareholder equity of ₹182.0M and total debt of ₹4.4M, which brings its debt-to-equity ratio to 2.4%. Its total assets and total liabilities are ₹470.8M and ₹288.8M respectively. Biofil Chemicals and Pharmaceuticals's EBIT is ₹8.1M making its interest coverage ratio 19.6. It has cash and short-term investments of ₹22.8M.

Key information

2.4%

Debt to equity ratio

₹4.39m

Debt

Interest coverage ratio19.6x
Cash₹22.84m
Equity₹182.03m
Total liabilities₹288.80m
Total assets₹470.83m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 524396's short term assets (₹384.1M) exceed its short term liabilities (₹285.2M).

Long Term Liabilities: 524396's short term assets (₹384.1M) exceed its long term liabilities (₹3.6M).


Debt to Equity History and Analysis

Debt Level: 524396 has more cash than its total debt.

Reducing Debt: 524396's debt to equity ratio has reduced from 12% to 2.4% over the past 5 years.

Debt Coverage: 524396's debt is well covered by operating cash flow (545.4%).

Interest Coverage: 524396's interest payments on its debt are well covered by EBIT (19.6x coverage).


Balance Sheet


Discover healthy companies